HIVポイントオブケア（POC）検査市場：パイプラインレポート（開発段階、セグメント、地域・国、規制経路、主要企業）

HIVポイントオブケア（POC）Testsは、臨床検査室以外で患者が治療を受けている場所の近くで実施される医療診断検査と定義されます。POCは通常、臨床検査室以外の人員によって実施され、その結果は臨床的意思決定に用いられます。POCには、手動の手法から自動分析装置まで様々な複雑さと手順があります。POC機器は「ハンドヘルド」であることが多く、小型のポータブル分析装置であることもあります。

当レポートでは、HIVポイントオブケア（POC）検査市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

• HIVポイントオブケア（POC）検査の概要

第3章 開発中の製品

• HIVポイントオブケア（POC）検査 - 開発段階別パイプライン製品
• HIVポイントオブケア（POC）検査 - 地域別パイプライン製品
• HIVポイントオブケア（POC）検査 - 規制経路別パイプライン製品
• HIVポイントオブケア（POC）検査 - 推定承認日別パイプライン製品
• HIVポイントオブケア（POC）検査 - 進行中の臨床試験

第4章 HIVポイントオブケア（POC）検査- 企業が開発中のパイプライン製品

• HIVポイントオブケア（POC）検査企業- 開発段階別のパイプライン製品
• HIVポイントオブケア（POC）検査- 開発段階別のパイプライン製品

第5章 HIVポイントオブケア（POC）検査企業と製品の概要

第6章 HIVポイントオブケア（POC）検査- 最近の開発

第7章 付録

• 調査手法
• GlobalDataについて
• お問合せ
• 免責事項

List of Tables

List of Tables

• HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
• HIV Point of care (POC) Tests - Pipeline Products by Territory
• HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
• HIV Point of care (POC) Tests - Pi

List of Figures

List of Figures

• HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
• HIV Point of care (POC) Tests - Pipeline Products by Territory
• HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
• HIV Point of care (POC) Tests - P

Abstract

GlobalData's Medical Devices sector report, "HIV Point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the HIV Point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

HIV Point of care (POC) Tests is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. POC is typically performed by non-laboratory personnel and the results are used for clinical decision making. POC has a range of complexity and procedures that vary from manual methodologies to automated analyzers. POC devices are often 'handheld' or may be small portable analyzers.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the HIV Point of care (POC) Tests under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of HIV Point of care (POC) Tests and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of HIV Point of care (POC) Tests under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 HIV Point of care (POC) Tests Overview

3 Products under Development

• 3.1 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development
• 3.2 HIV Point of care (POC) Tests - Pipeline Products by Territory
• 3.3 HIV Point of care (POC) Tests - Pipeline Products by Regulatory Path
• 3.4 HIV Point of care (POC) Tests - Pipeline Products by Estimated Approval Date
• 3.5 HIV Point of care (POC) Tests - Ongoing Clinical Trials

4 HIV Point of care (POC) Tests - Pipeline Products under Development by Companies

• 4.1 HIV Point of care (POC) Tests Companies - Pipeline Products by Stage of Development
• 4.2 HIV Point of care (POC) Tests - Pipeline Products by Stage of Development

5 HIV Point of care (POC) Tests Companies and Product Overview

6 HIV Point of care (POC) Tests- Recent Developments

• 6.1 Oct 10, 2023: Trinity Biotech Welcomes the Decision of the High Court of Kenya to Strike Out the Applications to Prevent the Procurement of Trinscreen HIV by the Kenyan Ministry of Health
• 6.2 Sep 27, 2023: Update on MedMira's Regulatory Path in Canada and the USA
• 6.3 Jun 14, 2023: Atomo and Newfoundland Sign Agreement for HIV Testing in Europe
• 6.4 Mar 22, 2023: Trinity Biotech welcomes TrinScreen HIV's inclusion in the New Kenyan HIV Testing Algorithm
• 6.5 Feb 28, 2023: Significant purchase order for HIV self-tests for Europe

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer